Medicine and wagering: same terms, different concepts

Andrea Alberto Conti1

  • 1Department of Medical and Surgical Critical Care, University of Florence, Florence, Italy. Largo Brambilla 3, I-50134, Firenze, Italy. Tel: +39/055/4271514; Fax: +39/055/4271413; E-mail: andrea.conti@unifi.it. andrea.conti@unifi.it.

Insights

Medicine and wagering share common terms due to similar tasks like risk assessment and forecasting. This highlights how medical language can incorporate terminology from other fields, adapting meanings as needed.

Area of Science:

  • Linguistics
  • Medical Terminology
  • History of Medicine

Background:

  • Medicine and wagering appear unrelated but share fundamental terminology.
  • Key shared tasks include estimation and forecasting.
  • This linguistic overlap indicates a permeability of medical language.

Purpose of the Study:

  • To explore the shared terminology between medicine and wagering.
  • To identify the underlying reasons for this linguistic convergence.
  • To understand the historical context of medical term adoption.

Main Methods:

  • Comparative analysis of terminology in medical and wagering contexts.
  • Examination of statistical and probabilistic roots of shared terms.
  • Historical review of medical language evolution.

Main Results:

  • A significant overlap in terms related to estimation, forecasting, and risk assessment was identified.
  • Shared terms originate from analogous statistical concepts.
  • The study confirms the historical tendency for medical language to absorb terms from other domains.

Conclusions:

  • The convergence of terms in medicine and wagering stems from shared probabilistic and forecasting functions.
  • Medical terminology has historically been receptive to external linguistic influences.
  • While terms may be shared, their specific meanings and applications evolve within the medical context.

Related Concept Videos

Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
231
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.5K
Drug Nomenclature01:17

Drug Nomenclature

During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
3.3K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.2K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
1.4K
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
228